Myriad Genetics Inc (MYGN)

EBITDA Growth

87.36%

TTM · Period ending:

MYGN logo

MYGN EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported87.36%
MYGN TTM EBITDA YoY % (-85.19% → 87.36%)
High-resolution chart · PNG

MYGN ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Myriad Genetics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-14.127%
-20.192%
-24.2639%
-1.7094%
12.6564%
20.8698%
29.2788%
17.7344%
3.6951%
-49.8192%
-47.9452%
-20.6897%
2%
47.2441%
37.6068%
9.375%
-85.1852%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.